piracetam has been researched along with Cerebral Infarction in 15 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Excerpt | Relevance | Reference |
|---|---|---|
| "This article investigated the clinical effects of piracetam with nimodipine in the treatment of vascular dementia (VD) after cerebral infarction." | 7.96 | Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction. ( Lei, Z; Wenjing, L; Zhaomin, C; Zongfang, Z, 2020) |
| "GABA and Piracetam caused the improvement of the morphological state of cerebral infarction, due to intracarotid infusion of Arachidonic acid." | 7.68 | [Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders]. ( Amroian, EA; Balian, LS; Parsamian, LK; Vartazarian, ND, 1990) |
| "This article investigated the clinical effects of piracetam with nimodipine in the treatment of vascular dementia (VD) after cerebral infarction." | 3.96 | Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction. ( Lei, Z; Wenjing, L; Zhaomin, C; Zongfang, Z, 2020) |
| "In this study, the temporal development of focal cerebral infarction induced by permanent middle cerebral artery occlusion (pMCAO) and the effects of piracetam, a derivative of gamma-aminobutyric acid widely used in clinical practice as a nootropic agent, on infarct area and volume were investigated." | 3.71 | The 2-oxopyrrolidinacetamide piracetam reduces infarct brain volume induced by permanent middle cerebral artery occlusion in male rats. ( Amoroso, S; Annunziato, L; DiRenzo, G; Minale, M; Pignataro, G; Tortiglione, A, 2002) |
| "GABA and Piracetam caused the improvement of the morphological state of cerebral infarction, due to intracarotid infusion of Arachidonic acid." | 3.68 | [Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders]. ( Amroian, EA; Balian, LS; Parsamian, LK; Vartazarian, ND, 1990) |
| "Seizures are rare manifestation of thalamic disorder." | 1.46 | Unilateral Thalamic Infarct Presenting as a Convulsive Seizure. ( Brohi, H; Kumar, R; Mughul, A, 2017) |
| "Treatment with oxiracetam (400 mg/kg/d p." | 1.28 | Effect of oxiracetam on cerebrovascular impairment in rats. ( Hasegawa, Y; Inukai, T; Kometani, M; Nakao, N; Okada, M; Takemori, E, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zongfang, Z | 1 |
| Wenjing, L | 1 |
| Zhaomin, C | 1 |
| Lei, Z | 1 |
| Kumar, R | 1 |
| Brohi, H | 1 |
| Mughul, A | 1 |
| Ali, K | 1 |
| Derev'yannykh, EA | 1 |
| Bel'skaya, GN | 1 |
| Knoll, EA | 1 |
| Krylova, LG | 1 |
| Popov, DV | 1 |
| Tortiglione, A | 1 |
| Minale, M | 1 |
| Pignataro, G | 1 |
| Amoroso, S | 1 |
| DiRenzo, G | 1 |
| Annunziato, L | 1 |
| Xerri, C | 1 |
| Zennou-Azogui, Y | 1 |
| Zhong, SQ | 1 |
| Sun, LJ | 1 |
| Yan, YZ | 1 |
| Sun, YQ | 1 |
| Zhong, YY | 1 |
| Chan, S | 1 |
| Ros, S | 1 |
| You, KY | 1 |
| Nhem, S | 1 |
| Salle, JY | 1 |
| Dudognon, P | 1 |
| Daviet, JC | 1 |
| Dierckx, RA | 1 |
| Dobbeleir, A | 1 |
| Pickut, BA | 1 |
| Timmermans, L | 1 |
| Dierckx, I | 1 |
| Vervaet, A | 1 |
| Vandevivere, J | 1 |
| Deberdt, W | 2 |
| De Deyn, PP | 1 |
| Enderby, P | 1 |
| Broeckx, J | 1 |
| Hospers, W | 1 |
| Schildermans, F | 1 |
| Rösel, T | 1 |
| Schneider, J | 1 |
| Fischer, JT | 1 |
| Druschky, KF | 1 |
| Kawiak, W | 1 |
| Pilarczyk, M | 1 |
| Chmielewska, B | 1 |
| Gieracz-Nazar, A | 1 |
| Kometani, M | 1 |
| Okada, M | 1 |
| Takemori, E | 1 |
| Hasegawa, Y | 1 |
| Nakao, N | 1 |
| Inukai, T | 1 |
| Amroian, EA | 1 |
| Vartazarian, ND | 1 |
| Parsamian, LK | 1 |
| Balian, LS | 1 |
| Herrschaft, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Escitalopram and Language Intervention for Subacute Aphasia (ELISA)[NCT03843463] | Phase 2 | 88 participants (Anticipated) | Interventional | 2021-07-18 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for piracetam and Cerebral Infarction
| Article | Year |
|---|---|
Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction.
Topics: Acute Disease; Adult; Aged; Aspirin; Blood Viscosity; Capsules; Cerebral Infarction; Cytidine Diphos | 2005 |
Technetium-99m HMPAO SPET in acute supratentorial ischaemic infarction, expressing deficits as millilitre of zero perfusion.
Topics: Aged; Cerebral Infarction; Cerebrovascular Circulation; Double-Blind Method; Female; Humans; Male; O | 1995 |
Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study.
Topics: Aged; Aphasia; Cerebral Infarction; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropro | 1994 |
The effect of piracetam on the content of glucose in the blood of patients with cerebral infarction at the very early stage of the illness.
Topics: Aged; Aged, 80 and over; Blood Glucose; Cerebral Infarction; Humans; Middle Aged; Piracetam | 1992 |
[The effectiveness of piracetam in acute cerebral ischemia in the human. A clinical controlled double-blind study of piracetam/10% dextran 40 versus 10% dextran 40/placebo].
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Cerebral Infarction; Clinical Trials as Topic; Dextr | 1988 |
10 other studies available for piracetam and Cerebral Infarction
| Article | Year |
|---|---|
Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction.
Topics: Aged; Calcium Channel Blockers; Case-Control Studies; Cerebral Infarction; Cerebrovascular Circulati | 2020 |
Unilateral Thalamic Infarct Presenting as a Convulsive Seizure.
Topics: Aspirin; Atorvastatin; Cerebral Angiography; Cerebral Infarction; Humans; Hydrocephalus; Levetiracet | 2017 |
The temporal crescent syndrome.
Topics: Aged; Anticonvulsants; Cerebral Infarction; Epilepsy; Female; Humans; Levetiracetam; Piracetam; Synd | 2015 |
Experience in the use of Actovegin in the treatment of patients with cognitive disorders in the acute period of stroke.
Topics: Aged; Brain Ischemia; Central Nervous System Stimulants; Cerebral Infarction; Cerebrovascular Circul | 2008 |
The 2-oxopyrrolidinacetamide piracetam reduces infarct brain volume induced by permanent middle cerebral artery occlusion in male rats.
Topics: Animals; Cerebral Infarction; Dose-Response Relationship, Drug; Ligation; Male; Middle Cerebral Arte | 2002 |
Influence of the postlesion environment and chronic piracetam treatment on the organization of the somatotopic map in the rat primary somatosensory cortex after focal cortical injury.
Topics: Afferent Pathways; Animals; Brain Injuries; Brain Ischemia; Brain Mapping; Cell Death; Cerebral Infa | 2003 |
[The management of stroke in Phnom Penh, Cambodia].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Calcium Channe | 2007 |
[Carbamazepine poisoning caused by confusing the drugs].
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Cerebral Infarction; Diagnosis, Differential; Drug Over | 2000 |
Effect of oxiracetam on cerebrovascular impairment in rats.
Topics: Animals; Behavior, Animal; Benzoquinones; Blood Pressure; Cerebral Arteries; Cerebral Infarction; Ce | 1991 |
[Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders].
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Brain; Cerebral Infarction; Cerebrovascular Disorders; | 1990 |